<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="are methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), multi-drug-resistant Mycobacterium" exact="tuberculosis" post="(MDR-TB), and Klebsiella pneumoniae carbapenemase-producing bacteria [ 13]. Moreover,"/>
 <result pre="as a nidus for systemic pathogenic infections, including dental cavities," exact="periodontal disease," post="pneumonia associated with cystic fibrosis, otitis media, osteomyelitis, bacterial"/>
 <result pre="nidus for systemic pathogenic infections, including dental cavities, periodontal disease," exact="pneumonia" post="associated with cystic fibrosis, otitis media, osteomyelitis, bacterial prostatitis,"/>
 <result pre="pathogenic infections, including dental cavities, periodontal disease, pneumonia associated with" exact="cystic fibrosis," post="otitis media, osteomyelitis, bacterial prostatitis, native valve endocarditis, meloidosis,"/>
 <result pre="including dental cavities, periodontal disease, pneumonia associated with cystic fibrosis," exact="otitis media," post="osteomyelitis, bacterial prostatitis, native valve endocarditis, meloidosis, and musculoskeletal"/>
 <result pre="most common device-related infections are central line-associated bloodstream infection, ventilator-associated" exact="pneumonia" post="(VAP), and Foley catheter-associated urinary tract infection (UTI) ["/>
 <result pre="central line-associated bloodstream infection, ventilator-associated pneumonia (VAP), and Foley catheter-associated" exact="urinary tract infection" post="(UTI) [ 53]. Studies have shown that 60–70% of"/>
 <result pre="22% are surgical site infections, 15% can be attributed to" exact="pneumonia" post="and lung infections, and 14% constitute bloodstream infections ["/>
 <result pre="valves in patients with pre-existing cardiac disease, causing Candida infectious" exact="endocarditis" post="[ 35]. It is known that biofilms of Candida"/>
 <result pre="infections that result in significant morbidity and mortality, especially in" exact="cystic fibrosis" post="patients [ 61, 62]. S. aureus and S. epidermidis"/>
 <result pre="[ 81]. A number of PSMs have been used against" exact="cancer" post="cells, whereas others are currently used in food preservation"/>
 <result pre="range from relatively minor incidences of irritation and sensitization, to" exact="contact dermatitis" post="and the most serious anaphylactic reaction, thus, should be"/>
 <result pre="from relatively minor incidences of irritation and sensitization, to contact" exact="dermatitis" post="and the most serious anaphylactic reaction, thus, should be"/>
 <result pre="10.1021/jp0603278 17078616 178. Selvaag E. Holm J.Ø. Thune P. Allergic" exact="contact dermatitis" post="in an aroma therapist with multiple sensitizations to essential"/>
 <result pre="17078616 178. Selvaag E. Holm J.Ø. Thune P. Allergic contact" exact="dermatitis" post="in an aroma therapist with multiple sensitizations to essential"/>
 <result pre="355 10.1111/j.1600-0536.1995.tb02058.x 179. Bleasel N. Tate B. Rademaker M. Allergic" exact="contact dermatitis" post="following exposure to essential oils Aust. J. Dermatol. 2002"/>
 <result pre="10.1111/j.1600-0536.1995.tb02058.x 179. Bleasel N. Tate B. Rademaker M. Allergic contact" exact="dermatitis" post="following exposure to essential oils Aust. J. Dermatol. 2002"/>
 <result pre="E. Geier J. Lessmann H. Schnuch A. Frosch P. Contact" exact="allergy" post="to essential oils: Current patch test results (2000–2008) from"/>
 <result pre="the swelling associated with the efferent phase of a contact" exact="hypersensitivity" post="response Inflamm. Res. 2002 51 236 244 10.1007/PL00000299 12056511"/>
</results>
